| Filed On | Filing |
|---|---|
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, November 4, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. |
| 15 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
(b) On October 9, 2026, David B. Roberts notified LeMaitre Vascular, Inc. (the “Company”) of his intent to retire as an employee of the Company, including as its President, effective as of December 31, 2026. Mr. Roberts was reelected as ... |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, August 4, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. |
| 05 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
(a) On June 2, 2026, LeMaitre Vascular, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 22,847,798 shares of the Company’s common stock were entitled to vote as of April 6, 2026, the r... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, May 5, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. |
| 14 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 25 Feb 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, February 25, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance. |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, November 6, 2025 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. |
| 05 Aug 2025 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, August 5, 2025 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. |
| 03 Jun 2025 |
8-K: Submission of Matters to a Vote of Security Holders
(a) On June 2, 2025, the Company held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 22,594,362 shares of the Company's common stock were entitled to vote as of April 8, 2025, the record date for the Annual Me... |
| 01 May 2025 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, May 1, 2025 - LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. |
| 27 Feb 2025 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, February 27, 2025 - LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend of $0.20/share (+25%), and provided guidance. |
| 13 Feb 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On behalf of LeMaitre Vascular, Inc., I am pleased to offer you the position of Chief Financial Officer, reporting to George LeMaitre, Chairman & Chief Executive Officer, with a start date of Monday, March 10, 2025. This offer of employm... |
| 19 Dec 2024 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
INDENTURE, dated as of December 19, 2024 between LeMaitre Vascular, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). |
| 17 Dec 2024 |
8-K: Regulation FD Disclosure
BOSTON, MA, December 16, 2024 -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced the pricing of its offering of $150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the “notes”) in a pri... |
| 16 Dec 2024 |
8-K: Regulation FD Disclosure
BOSTON, MA, December 16, 2024 -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate principal amount of Convertible Senior Notes due ... |
| 31 Oct 2024 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, October 31, 2024 - LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance. |
| 26 Aug 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
(b) On August 26, 2024, LeMaitre Vascular, Inc. (the “Company”), announced that Joseph P. Pellegrino, Jr. will retire as an employee of the company, including as Chief Financial Officer, effective as of March 7, 2025, following the antic... |
| 01 Aug 2024 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, August 1, 2024 - LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly dividend and provided guidance. |
| 03 Jun 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The name of the plan is the LeMaitre Vascular, Inc. Fourth Amended and Restated 2006 Stock Option and Incentive Plan (the “Plan”), which is the amendment and restatement of the Third Amended and Restated 2006 Stock Option and Incentive P... |
Loading...